Corporate

Video: DKFZ - Research for a Life Without Cancer

Two leading experts discuss the impact of next-generation sequencing in Germany

DKFZ - Research for a Life Without Cancer
September 6, 2016

The German Cancer Research Center (DKFZ) is the foremost cancer research institute in Germany with key collaborations to enable personalized medicine for oncology.  Illumina has been given access to talk to two of DKFZ’s leading experts to discuss the impact next-generation sequencing has had at DKFZ and its partner institute the National Center for Tumor Diseases (NCT).

Cancer is a disease that poses enormous challenges to research, because every cancer is different and its course can vary immensely even from one patient to the next. DKFZ is tasked with performing cancer research according to its statutes. It is the largest biomedical research institute in Germany and a member of the Helmholtz Association of National Research Centers. In 90 divisions and research groups, they have more than 1,200 scientists investigating the mechanisms of cancer, identifying cancer risk factors and are trying to find strategies to prevent people from getting cancer.

They are developing novel approaches to make tumor diagnosis more precise and treatment of cancer patients more successful, using the high throughput sequencing capabilities of the HiSeq X Ten System.

 

*Additional video courtesy of DKFZ.

Recent Articles

Trailblazing study shows early CGP leads to better precision treatments
Trailblazing study shows early CGP leads to better precision treatments
How two systems integration scientists ensure a smooth workflow on MiSeq i100
How two systems integration scientists ensure a smooth workflow on MiSeq i100
Single-cell RNA analysis finds possible genetic drivers of bone cancer
Single-cell RNA analysis finds possible genetic drivers of bone cancer